glp 1 agonist eye side effects A potentially blinding condition is a very rare effect of the GLP-1 receptor semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no GLP-1RA Essentials in Gastroenterology: Side
Description
Available from: Kosiborod MN, Bhatta M, Davies M, Deanfield JE, Garvey WT, Khalid U, Kushner R, Rubino DM, Zeuthen N, Verma S
MACE: major cardiovascular events
GLP-1 +3 Mar 19, 2026 7 min read A shift in what's possible for diabetes and obesity GLP-1 +5 Dec 16, 2025 40 min read Incretins are changing the narrative of chronic kidney disease GLP-1 +3 Dec 11, 2025 10 min read Bariatric surgery in a shot
Most adverse events were mild to moderate gastrointestinal events, primarily occurring during the dose-escalation period
Chin Med J (Engl) (2012) 125(8):145764
I.V., Intravenous
